We're sunsetting PodQuest on 2025-07-28. Thank you for your support!
Export Podcast Subscriptions
back
#240 ‒ The confusion around HDL and its link to cardiovascular disease | Dan Rader, M.D.
01:54:10
Share
2023/1/30
The Peter Attia Drive
AI Chapters
Transcribe
Chapters
What is the lipidology of apoB and apoA?
A primer on the high-density lipoprotein (HDL): genesis, structure, and more
How does the lipoprotein system differ in humans compared to other mammals?
Clarifying the terminology around HDL and apoA
What is HDL metabolism?
Do CETP inhibitors for raising HDL-C reduce CVD risk?
Why are hard outcome trials important in cardiovascular medicine?
What is the role of SR-B1, an HDL receptor important for cholesterol efflux?
Are HDL levels and atherosclerosis causally linked?
How does insulin resistance impact HDL, and what insights does HDL-C provide into triglyceride metabolism?
What were the disappointing results from the studies of niacin?
What is HDL lipidation, dilapidation, and reverse cholesterol transport?
Is measuring the cholesterol efflux capacity of HDL a better predictor of ASCVD risk than HDL-C?
What is a promising new intervention that may promote cholesterol efflux and reverse cholesterol transport?
What is the association between HDL cholesterol and neurodegenerative diseases?
What are the challenges ahead, promising outlook, and the next frontier in lipidology?
Shownotes
Transcript
No transcript made for this episode yet, you may request it for free.